Student name

South University

NSG-5003

Professor Name

Submission Date

Jennifer Whitaker NSG 5003 Week 6 Reflection Discussion

In the context of the two cases, it is necessary to mention the impossibility to treat chronic endocrine diseases easily and the importance of patient-oriented and proactive treatment. Case Study 1: Ms. Jefferson reported no symptoms; however, her tests of thyroid functioning were rather abnormal, and it was primary hypothyroidism. This underscores that laboratory observation is extremely essential since the patients may have an underlying disease that is very severe and which does not have any definitive clinical symptoms. It also emphasizes the role of a timely diagnosis and adequate follow-up that encompasses complications prevention, e.g., fatigue, weight gain, or cardiovascular development, in an asymptomatic population (Bengtsson et al., 2023).

In Case Study 2, the outcome of the pharmacologic therapy on the chronic disease management is demonstrated. The patient is also having type 2 diabetes that is difficult to control because she has been under systemic prednisone treatment for severe asthma. The corticosteroids can be associated with hyperglycemia due to an increase in insulin resistance and glucose release into the liver (Cho and Suh, 2024). The specified situation means that there is a need to oversee this process on a regular basis, individualize the treatment process, and inform the patient of potential side effects, including the probability of infection, weight gain, and blood sugar fluctuations.

Together, these situations illustrate the necessity to pay special attention to careful evaluation, training, and interprofessional cooperation. To prevent complications, clinicians should be aware of how therapies, comorbidities, and disease processes would interact and alter interventions. The two cases show that laboratory findings and patient history are equally significant in clinical decision-making, and therefore, care must be ensured to be cautious even with healthy patients. The patient will be able to engage in the treatment process actively by educating them about symptom awareness, lifestyle modifications, and follow-up plans, which will contribute to improved outcomes and quality of life (Struja et al., 2024). These ideas improve my understanding of the fact that the management process of endocrine diseases involves a set of clinical decisions, patient interactions, and constant observations to ensure the most positive outcomes over the long-term health of a patient.

References

Bengtsson, E., Anders Funkquist, & Björn Agvall. (2023). Observational study of diagnosis and management in adult primary hypothyroidism in the southwest of Sweden. Scandinavian Journal of Primary Health Care, 41(3), 189–195. https://doi.org/10.1080/02813432.2023.2213748

Cho, J.-H., & Suh, S. (2024). Glucocorticoid-induced hyperglycemia: A neglected problem. Endocrinology and Metabolism, 39(2), 222–238. https://doi.org/10.3803/EnM.2024.1951